TYRA
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2656 State St, Carlsbad, California, 920...Phone Number
(619) 728-4760Website
tyra.bioRevenue
$104.2 MillionStock Symbol
TYRAIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
2
2
1
About TYRA
Tyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology. The Company's in-house precision medicine platform, SNP, enables the rapid and precise refinement of structural drug design through iterative molecular SNPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA's initial focus is on applying its accelerated small molecule drug discovery engine to develop therapies in targeted oncology and genetically defined conditions. TYRA is based in Carlsbad, CA.Explore more
TYRA Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is TYRA your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when TYRA launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once TYRA has new funding data
Earning: See what the market has to say on TYRA recently announced quarterly report
Check out if TYRA is spiking on competitors!
Click to see if TYRA had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at TYRA
Check if TYRA has recently received funding, and reach out quickly before it becomes old news!
TYRA, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to TYRA
Compare insights from companies similar to TYRA, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
TYRA is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
TYRA is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about TYRA.
TYRA financials insights
Gather financial insights about TYRA, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$50M
2021
Series B
$106M
Share Placement
$172.8M
2024
Other Financing Round
$200M
TYRA Tech Stack
A closer look at the technologies used by TYRA
Most Recent Scoops
Person-Based
Medical Research
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Hiring Plans
TYRA has more open roles in Legal than it has had at any time in the past 12 months. Technologies mentioned include: Remote.
Hiring Plans
Project
Clinical Operations
TYRA News & Media
Tyra Biosciences, Inc. (TYRA) Discusses Initial SURF302 Results on Oral Dabogratinib for Intermediate Risk NMIBC Transcript
Tyra Biosciences, Inc. (TYRA) Discusses Initial SURF302 Results on Oral Dabogratinib for Intermediate Risk NMIBC September 9, 2026 8:00 AM EDTCompany...Tyra Biosciences Reports Initial Phase 2 SURF302 Results Supporting the First Potential Oral Innovation in LG IR NMIBC with Dabogratinib
TYRA's mission is to make dabogratinib the clear first-line treatment choice for patients with LG IR NMIBC Favorable safety and tolerability results support chronic dosing potential No clinically significant hyperphosphatemia, nail toxicity or ocular toxicity; low frequency of...Tyra Biosciences to Present at the Cantor Global Healthcare Conference
CARLSBAD, Calif., Sept. 8, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced...Tyra Biosciences to Host Conference Call on Initial Results of Oral Dabogratinib from the SURF302 Phase 2 Study for IR NMIBC on September 9, 2026
CARLSBAD, Calif., Sept. 4, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced that...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding TYRA
Sign Up For FreeTo access detailed company insights
Tyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology. The Company's in-house precision medicine platform, SNP, enables the rapid and precise refinement of structural drug design through iterative molecular SNPshots th... Read More
